✨ Free AI Report
Fresh Tracks Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Fresh Tracks Therapeutics, Inc.
Research Preview

Fresh Tracks Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a...

Analyst-debate audio for Fresh Tracks Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Fresh Tracks Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Fresh Tracks Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
1/ 10Challenged

Cyborg Score thesis

Company is no longer operational; historical investment value has been extinguished....

Read the full analyst-debate transcript →
Industry Clinical-stage biopharmaceuticals
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Fresh Tracks Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Fresh Tracks Therapeutics, Inc. Overview

Pro stress-test →

Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a delisting from Nasdaq in December 2023 and subsequent trading on the OTC Pink market.

Strategic Profile

Pro stress-test →

The company was formerly known as Brickell Biotech, Inc. and rebranded in September 2022. Prior to dissolution, it aimed to leverage experienced leadership with track records in commercializing first-in-class pharmaceutical products.

Competitive Landscape

Pro stress-test →

N/A - Company is dissolved

Industry Context

Fresh Tracks Therapeutics, Inc. operates in Clinical-stage biopharmaceuticals.

Key facts

Founded: 1987 · Headquarters: Boulder, US · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Fresh Tracks Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Fresh Tracks Therapeutics, Inc. has a new material development →

Compare Fresh Tracks Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Fresh Tracks Therapeutics, Inc. operates in Clinical-stage biopharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Clinical-stage biopharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Fresh Tracks Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Fresh Tracks Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Fresh Tracks Therapeutics, Inc. do this quarter?”
“Is Fresh Tracks Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Fresh Tracks Therapeutics, Inc. do?+
Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a...
What is Fresh Tracks Therapeutics, Inc.'s Cyborg Score?+
Fresh Tracks Therapeutics, Inc. has a Cyborg Score of 1/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Fresh Tracks Therapeutics, Inc.'s main competitors?+
The full competitive landscape for Fresh Tracks Therapeutics, Inc. is in the AskCyborg report.
How can I get the full Fresh Tracks Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Fresh Tracks Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Fresh Tracks Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.